Effects of Chemotherapy on DNA Mismatch Repair-Deficient Tumor Cells
Author Information
Author(s): D Fink, S Nebel, PS Norris, S Aebi, HK Kim, M Haas, SB Howell
Primary Institution: University of California at San Diego
Hypothesis
Does loss of DNA mismatch repair affect drug sensitivity and enrichment of tumor cells?
Conclusion
Loss of DNA mismatch repair leads to increased resistance to certain chemotherapeutic agents and enriches for mismatch repair-deficient cells.
Supporting Evidence
- Loss of DNA mismatch repair is linked to resistance against 6-thioguanine, cisplatin, and carboplatin.
- Enrichment assays showed that treatment with certain drugs increased the proportion of mismatch repair-deficient cells.
- Resistance to drugs was confirmed through clonogenic assays.
Takeaway
Some cancer cells can become resistant to drugs because they can't fix their DNA mistakes, making them harder to kill with treatment.
Methodology
The study used clonogenic assays and flow cytometry to assess drug sensitivity and enrichment of mismatch repair-deficient cells.
Limitations
The study may not account for all variables affecting drug resistance in clinical settings.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website